Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Friday 20 February, 2015

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 4896F
GlaxoSmithKline PLC
20 February 2015
 

GlaxoSmithKline plc

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

 

In accordance with DTR 3.1.4 R(1)(a) and (c) GlaxoSmithKline plc (GSK) was advised on 20 February 2015 of the following increase in the notional allocation of GSK American Depositary Shares (ADSs) on 19 February 2015, at a price of $47.03 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401K plan:

 

 

Director/PDMR

 

Number of ADSs

 

Mr W C Louv

 

27

 

Dr M M Slaoui

 

20

 

 

 

Connected person

 

Number of ADSs

 

Dr K Slaoui (connected person of Dr M M Slaoui)

 

 

17

 

 

V A Whyte

Company Secretary

 

20 February 2015

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFBLFLELFEBBE

a d v e r t i s e m e n t